[HTML][HTML] Evaluation of the Safety and Efficacy of Repeated Mesenchymal Stem Cell Transplantations in ALS Patients by Investigating Patients' Specific Immunological …
Z Alkhazaali-Ali, S Sahab-Negah, AR Boroumand… - Diseases, 2024 - mdpi.com
Background: Amyotrophic lateral sclerosis (ALS) is an incurable disease. There are vigorous
attempts to develop treatments to reduce the effects of this disease, and among these …
attempts to develop treatments to reduce the effects of this disease, and among these …
Evaluation of the Safety and Efficacy of Repeated Mesenchymal Stem Cell Transplantations in ALS Patients by Investigating Patients' Specific Immunological and …
Z Alkhazaali-Ali, S Sahab-Negah… - Diseases (Basel …, 2024 - europepmc.org
Background Amyotrophic lateral sclerosis (ALS) is an incurable disease. There are vigorous
attempts to develop treatments to reduce the effects of this disease, and among these …
attempts to develop treatments to reduce the effects of this disease, and among these …
Evaluation of Safety and Efficacy of Repeated Mesenchymal Stem Cell Transplantations in ALS Patients by Investigating Patient's Specific Immunological and …
Z Alkhazaali, S Sahab-Negah, AR Boroumand… - 2024 - preprints.org
Background: Amyotrophic lateral sclerosis (ALS) is an incurable disease. There are no
defined valid biomarkers for evaluating therapeutic outcomes of this disease. Numerous …
defined valid biomarkers for evaluating therapeutic outcomes of this disease. Numerous …
Evaluation of the Safety and Efficacy of Repeated Mesenchymal Stem Cell Transplantations in ALS Patients by Investigating Patients' Specific Immunological and …
Z Alkhazaali-Ali, S Sahab-Negah… - Diseases (Basel …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Amyotrophic lateral sclerosis (ALS) is an incurable disease. There are vigorous
attempts to develop treatments to reduce the effects of this disease, and among these …
attempts to develop treatments to reduce the effects of this disease, and among these …
[HTML][HTML] Evaluation of the Safety and Efficacy of Repeated Mesenchymal Stem Cell Transplantations in ALS Patients by Investigating Patients' Specific Immunological …
Z Alkhazaali-Ali, S Sahab-Negah, AR Boroumand… - Diseases, 2024 - ncbi.nlm.nih.gov
Background: Amyotrophic lateral sclerosis (ALS) is an incurable disease. There are vigorous
attempts to develop treatments to reduce the effects of this disease, and among these …
attempts to develop treatments to reduce the effects of this disease, and among these …
Evaluation of the Safety and Efficacy of Repeated Mesenchymal Stem Cell Transplantations in ALS Patients by Investigating Patients' Specific Immunological and …
Z Alkhazaali-Ali, S Sahab-Negah, AR Boroumand… - …, 2024 - search.ebscohost.com
Background: Amyotrophic lateral sclerosis (ALS) is an incurable disease. There are vigorous
attempts to develop treatments to reduce the effects of this disease, and among these …
attempts to develop treatments to reduce the effects of this disease, and among these …
Evaluation of Safety and Efficacy of Repeated Mesenchymal Stem Cell Transplantation in Patients with ALS by Investigating Patient's Specific MicroRNAs as Novel …
Z Alkhazaali, S Sahab-Negah, AR Boroumand… - 2024 - europepmc.org
Background: Since there is no cure for amyotrophic lateral sclerosis (ALS) currently, it is very
important for searching diagnostic biomarkers and novel treatments to reduce the severity of …
important for searching diagnostic biomarkers and novel treatments to reduce the severity of …
Evaluation of Safety and Efficacy of Repeated Mesenchymal Stem Cell Transplantation in Patients with ALS by Investigating Patient's Specific MicroRNAs as Novel …
Z Alkhazaali, S Sahab-Negah, AR Boroumand… - 2024 - preprints.org
Background: Since there is no cure for amyotrophic lateral sclerosis (ALS) currently, it is very
important for searching diagnostic biomarkers and novel treatments to reduce the severity of …
important for searching diagnostic biomarkers and novel treatments to reduce the severity of …